Clorox (NYSE:CLX) Issues FY 2027 Earnings Guidance

by · The Markets Daily

Clorox (NYSE:CLX – Get Free Report) updated its FY 2027 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.700-6.000 for the period, compared to the consensus EPS estimate of 6.230. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.5 billion.

Clorox Stock Performance

CLX traded up $2.72 during midday trading on Monday, reaching $98.25. The company had a trading volume of 3,890,644 shares, compared to its average volume of 2,541,113. The business has a 50-day moving average of $95.51 and a two-hundred day moving average of $103.64. The company has a market cap of $11.88 billion, a P/E ratio of 15.95 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. Clorox has a 1 year low of $84.70 and a 1 year high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities research analysts predict that Clorox will post 5.52 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be given a $1.25 dividend. The ex-dividend date is Wednesday, August 12th. This is a positive change from Clorox’s previous quarterly dividend of $1.24. This represents a $5.00 annualized dividend and a dividend yield of 5.1%. Clorox’s dividend payout ratio (DPR) is presently 80.52%.

Analysts Set New Price Targets

Several research firms recently issued reports on CLX. UBS Group increased their target price on Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Jefferies Financial Group lowered shares of Clorox from a “buy” rating to a “hold” rating and dropped their target price for the stock from $125.00 to $98.00 in a research report on Tuesday, July 28th. Citigroup cut their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, BNP Paribas Exane decreased their price target on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a research note on Monday, July 20th. Twelve research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, Clorox presently has an average rating of “Reduce” and an average price target of $101.00.

Read Our Latest Stock Analysis on CLX

Insider Activity

In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.63% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox reported quarterly adjusted EPS of $1.66, ahead of the $1.64 consensus estimate, while revenue of $1.95 billion exceeded expectations of $1.91 billion. Clorox earnings press release
  • Positive Sentiment: Management projected fiscal 2027 revenue of approximately $7.6 billion to $7.7 billion, above the roughly $7.5 billion analyst consensus. The outlook reflects expected 13% to 14% sales growth, helped substantially by the GOJO acquisition.
  • Positive Sentiment: Clorox declared a quarterly dividend of $1.25 per share, up from $1.24, supporting the stock’s income appeal with an indicated yield of about 5.2%.
  • Neutral Sentiment: The company said it completed the GOJO acquisition in April and finished its U.S. enterprise-resource-planning implementation, important milestones that could support future execution but may require continued integration spending. Clorox reports fiscal 2026 results and fiscal 2027 outlook
  • Negative Sentiment: Fiscal 2026 remained weak: full-year sales declined 5% to $6.72 billion and diluted EPS fell 26% to $4.81. Fourth-quarter sales decreased 2% year over year, while reported diluted EPS dropped 50% to $1.34, reflecting cost pressures. Clorox fourth-quarter sales report
  • Negative Sentiment: Fiscal 2027 EPS guidance of $5.70 to $6.00 is below the $6.23 consensus estimate. Clorox also warned that inflation and consumers’ increasing focus on value are creating a difficult operating environment, keeping pressure on margins and demand. Clorox projects a difficult fiscal 2027

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after acquiring an additional 514 shares during the last quarter. Woodline Partners LP boosted its holdings in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after purchasing an additional 7,465 shares during the period. Baird Financial Group Inc. increased its holdings in Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after purchasing an additional 424 shares during the period. Jump Financial LLC raised its position in Clorox by 173.5% during the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after purchasing an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia grew its holdings in Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after acquiring an additional 3,352 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also